Pitfalls of cell therapy manufacturing IP - A case study (T 0868/23)
The recent Board of Appeal decision in T 0868/23 is a powerful example of the potential fragility of process IP in the field of cell therap...
Dr Rose Hughes -
Monday, July 07, 2025
Pitfalls of cell therapy manufacturing IP - A case study (T 0868/23)
Reviewed by Dr Rose Hughes
on
Monday, July 07, 2025
Rating:
Reviewed by Dr Rose Hughes
on
Monday, July 07, 2025
Rating: